The optimal time for the initiation of in vitro fertilization and embryo transfer among women with atypical endometrial hyperplasia and endometrial carcinoma receiving fertility-sparing treatment

被引:0
|
作者
Ziyi Song
Huixin Liu
Rong Zhou
Zerui Xiao
Jianliu Wang
Haibo Wang
Qun Lu
机构
[1] Peking University People’s Hospital,Center of Reproductive Medicine
[2] Peking University People’s Hospital,Department of Clinical Epidemiology
[3] Peking University People’s Hospital,Department of Obstetrics and Gynecology
[4] Peking University Clinical Research Institute,undefined
[5] Peking University First Hospital,undefined
来源
Archives of Gynecology and Obstetrics | 2022年 / 305卷
关键词
Endometrial cancer; Fertility-sparing treatment; IVF-ET; Controlled ovarian hyperstimulation; Pregnancy outcome;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1215 / 1223
页数:8
相关论文
共 50 条
  • [1] The optimal time for the initiation of in vitro fertilization and embryo transfer among women with atypical endometrial hyperplasia and endometrial carcinoma receiving fertility-sparing treatment
    Song, Ziyi
    Liu, Huixin
    Zhou, Rong
    Xiao, Zerui
    Wang, Jianliu
    Wang, Haibo
    Lu, Qun
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2022, 305 (05) : 1215 - 1223
  • [2] Molecular classification in fertility-sparing treatment of endometrial carcinoma and atypical endometrial hyperplasia
    Martin, Tiermes Marina
    Matas, Isabel
    Munmany, Meritxell
    Celada, Cristina
    Diaz-Feijoo, Berta
    Glickman, Ariel
    Carreras, Nuria
    Fuste, Pere
    Torne, Aureli
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A245 - A246
  • [3] A practical guideline on the fertility-sparing treatment of patients with endometrial carcinoma and atypical endometrial hyperplasia
    Catena, Ursula
    Macklon, Kirsten Louise Tryde
    Rodolakis, Alexandros
    Scambia, Giovanni
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2025,
  • [4] Fertility-Sparing Treatment for Endometrial Cancer or Atypical Endometrial Hyperplasia Patients With Obesity
    Chen, Junyu
    Cao, Dongyan
    Yang, Jiaxin
    Yu, Mei
    Zhou, Huimei
    Cheng, Ninghai
    Wang, Jinhui
    Zhang, Ying
    Peng, Peng
    Shen, Keng
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [5] Outcome of fertility-sparing treatment with medroxyprogesterone acetate for atypical hyperplasia and endometrial carcinoma in young Japanese women
    Kataoka, H.
    Mori, T.
    Yamamoto, T.
    Sawada, M.
    Kuroboshi, H.
    Tatsumi, H.
    Iwasaku, K.
    Kitawaki, J.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2014, 35 (01) : 11 - 15
  • [6] Prospective study of fertility-sparing treatment with chlormadinone acetate for endometrial carcinoma and atypical hyperplasia in young women
    Ouasti, Samia
    Bucau, Margot
    Larouzee, Elise
    Clement De Givry, Sebastien
    Chabbert-Buffet, Nathalie
    Koskas, Martin
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2022, 157 (02) : 452 - 457
  • [7] Fertility-sparing management of endometrial cancer and atypical hyperplasia
    Gonthier, C.
    Trefoux-Bourdet, A.
    Luton, D.
    Koskas, M.
    GYNECOLOGIE OBSTETRIQUE FERTILITE & SENOLOGIE, 2017, 45 (02): : 112 - 118
  • [8] Fertility-Sparing Treatment and Assisted Reproductive Technology in Patients with Endometrial Carcinoma and Endometrial Hyperplasia: Pregnancy Outcomes after Embryo Transfer
    Friedlander, Hilary
    Blakemore, Jennifer K.
    McCulloh, David H.
    Fino, M. Elizabeth
    CANCERS, 2023, 15 (07)
  • [9] Fertility-Sparing Treatment for Atypical Endometrial Hyperplasia and Endometrial Cancer: A Cochrane Systematic Review Protocol
    Maria-Eulalia Fernandez-Montoli
    Jordi Sabadell
    Nayanar-Adela Contreras-Perez
    Advances in Therapy, 2021, 38 : 2717 - 2731
  • [10] Fertility-Sparing Treatment for Atypical Endometrial Hyperplasia and Endometrial Cancer: A Cochrane Systematic Review Protocol
    Fernandez-Montoli, Maria-Eulalia
    Sabadell, Jordi
    Contreras-Perez, Nayanar-Adela
    ADVANCES IN THERAPY, 2021, 38 (05) : 2717 - 2731